Anticoagulants and Bleeding Disorders: Clinical Trials

3 trials for Anticoagulants and Bleeding Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 21Completed 1

Follow Anticoagulants and Bleeding Disorders: new trials by email Literature Review of Anticoagulants and Bleeding Disorders trials Research Report on Anticoagulants and Bleeding Disorders

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Feasibility of Argatroban As Anticoagulant in Adults with ECMO
Argatroban, Unfractionated heparin - Extracorporeal Membrane Oxygenation Complication, Anticoagulants and Bleeding Disorders
Phase 2 / Phase 3CompletedMedical University of Vienna402021-12-012024-09-19
A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic
Therapeutic anticoagulation - COVID, Coronavirus Infection
Phase 3CompletedUniversity of Sao Paulo General Hospital4652020-07-042021-10-26
Apixaban Versus Warfarin in Patients With Left Ventricular (LV) Thrombus
Apixaban Oral Tablet [Eliquis], Warfarin - Acute Myocardial Infarction, Left Ventricular Thrombosis
Phase 3CompletedHadassah Medical Organization402018-01-012021-08-25

Narrower conditions

Hemostatic Disorders (3)  ·  Coronavirus Infections (1)  ·  Severe Acute Respiratory Syndrome (1)  ·  Venous Thromboembolism (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Hemorrhagic Disorders (3)  ·  Vascular Diseases (3)  ·  Coronaviridae Infections (1)  ·  Embolism and Thrombosis (1)  ·  Infections (1)  ·  Nidovirales Infections (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Thromboembolism (1)  ·  Virus Diseases (1)

Interventions

Heparin (1)  ·  Warfarin (1)  ·  apixaban (1)  ·  argatroban (1)

Sponsors

Hadassah Medical Organization (1)  ·  Medical University of Vienna (1)  ·  University of Sao Paulo General Hospital (1)

Countries

Austria (1)  ·  Brazil (1)  ·  Israel (1)

Top investigators

Elnara M Negri, MD, PhD (1)  ·  Hassan Rahhal, MD (1)  ·  Heraldo P de Souza, MD, PhD (1)  ·  Peter Juni, MD, FESC (1)  ·  Ronny Alcalai (1)  ·  Thomas Staudinger, MD (1)

Results publications

PMID 34268513